May 31, 2011 – The American Food and Drug Administration (FDA) has released today the following announcement aimed at physicians, family practices, and patients: ISSUE: FDA is aware of two newly published studies that evaluated the risk of venous thromboembolism …

The Pill: Possibly Increased Risk of Blood Clots with Birth Control Pills Containing Drospirenone Read more »